Mirai (MIT breast cancer risk from mammograms)
Reads a mammogram to estimate five-year breast cancer risk, consistently across races and devices.
Science Translational Medicine 2021; validated across seven hospitals in several countries; used in risk-adapted screening trials.
Generic schematic · not to scale · placeholder for the ai computation front
Flagged finding · Neural network
How it works
Mirai applies deep learning to mammograms with device-conditional adversarial training.
Strengths
- Cross-site consistency
Limitations
- Prospective impact still under study
Since
2021
Latest papers
topLatest papers · live from Europe PMC
Query for this technology: (TITLE:"Mirai" OR ABSTRACT:"Mirai" OR TITLE:"MIT breast cancer risk from mammograms" OR ABSTRACT:"MIT breast cancer risk from mammograms") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Mirai (MIT breast cancer risk from mammograms), not a curated reading list.